Transaction in own shares and Issue of Equity

CT Global Managed Portfolio Trust
25 April 2023
 

TO:                  RNS

FROM:            CT Global Managed Portfolio Trust PLC

DATE:             25 April 2023

SUBJECT:      Transaction in own shares and Issue of Equity

LEI:                  213800ZA6TW45NM9YY31

 

 

The Board of CT Global Managed Portfolio Trust PLC ("the Company") announces that on 25 April 2023 the Company purchased 200,000 Growth shares of £0.064343979 each at a price of 223.25p per Growth share to be held in treasury and allotted 50,000 Income shares of £0.064343979 each, from the Company's general business purposes blocklisting facility at a price of 121.25p per Income share. These Income shares will rank pari passu with the existing Income shares in issue and dealings are expected to commence on 27 April 2023.

 

Following this issue, the Company has the ability to issue 2,259,510 Income shares and 1,304,550 Growth shares under its blocklisting facilities.

 

Following these transactions the Company's issued share capital consists of 50,155,503 Income shares and 38,847,949 Growth shares, of which nil Income shares and 615,000 Growth shares are held in treasury. Therefore the total number of shares with voting rights in CT Global Managed Portfolio Trust PLC is 50,155,503 Income shares and 38,232,949 Growth shares.

 

The above figures (50,155,503 Income shares and 38,232,949 Growth shares) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CT Global Managed Portfolio Trust PLC under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Peter Hewitt, Columbia Threadneedle Investment Business Limited 0131 573 8360

Ian Ridge, Columbia Threadneedle Investment Business Limited       0131 573 8316

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings